Michael Matson
Stock Analyst at Needham
(2.64)
# 2,143
Out of 4,761 analysts
22
Total ratings
66.67%
Success rate
12.41%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $175.64 | +140.83% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $9.91 | +808.17% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $103.16 | -48.62% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $80.28 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $231.69 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $104.49 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $47.44 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $382.78 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $16.51 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $64.49 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $63.30 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.21 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.12 | - | 1 | Feb 24, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $175.64
Upside: +140.83%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $9.91
Upside: +808.17%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $103.16
Upside: -48.62%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $80.28
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $231.69
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $104.49
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $47.44
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $382.78
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $16.51
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $64.49
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $63.30
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.12
Upside: -